Press Releases

 Filter by Provider

Regulatory News:

Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/NYSE: AZN) supplemental Biologics License Application (sBLA) for ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been accepted and granted Priority Review in the U.S. for the treatment of adult patients with HER2 positive (immunohistochemistry [IHC] 3+ or in-situ hybridization (ISH)+) breast cancer who have residual invasive disease after neoadjuvant HER2 targeted treatment.

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today results from the Phase III persevERA Breast Cancer study evaluating investigational giredestrant in combination with palbociclib for people with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer. The study did not meet its primary objective of a statistically significant improvement in progression-free survival in the intent-to-treat population versus letrozole plus palbociclib, but a numerical improvement was observed. The adverse events for the giredestrant combination were manageable and consistent with the known safety profiles of each individual treatment.

New proactive engagement solution aims to close the gap between early signals and meaningful follow-through

PARIS, FRANCE, 09 March 2026 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today that it is voluntarily withdrawing Tazverik® (tazemetostat) in all indications from all Ipsen markets. Ipsen’s decision to withdraw is based on emerging data from the ongoing Phase Ib/III SYMPHONY-1 trial (evaluating tazemetostat in combination with lenalidomide plus rituximab (R2) vs R2 in follicular lymphoma). The Independent Data Monitoring Committee (IDMC) advised that, based on adverse events of secondary hematologic malignancies, the risks may outweigh potential benefits for patients within this treatment regimen. As a result of these data, Ipsen is withdrawing Tazverik effective immediately, including both for follicular lymphoma (FL) and epithelioid sarcoma (ES).

Galderma (SIX: GALD) today announced Cetaphil, the dermatologist-recommended brand trusted by millions with sensitive skin, is launching its new Cetaphil AM/PM Antioxidant Serums, a breakthrough daily system clinically designed to defend skin by day and support accelerated repair by night for sensitive, stressed skin.

Business confidence around prospects for investment and growth in Europe is riding high despite recent economic and geopolitical challenges, according to new research among GCs across Europe and the U.S.

Pratteln, Switzerland, March 9, 2026 – Santhera Pharmaceuticals (SIX: SANN) today announced that full results from long-term real-world comparative analyses, including baseline data from the ongoing GUARDIAN study of AGAMREE® (vamorolone), were presented at the Muscular Dystrophy Association (MDA) Clinical & Scientific Conference 2026 in Orlando, Florida.

Agency Support Co-Leader Emphasizes Collaborative Systems and Balance in HighLevel Growth

Thinkrr.ai CMO Shares Scalable, HIPAA-Compliant Voice Solutions for 24/7 Business Automation

DSCVR has introduced a series of major product enhancements, marking a continued step forward in its evolution as an AI-native intelligence layer for Web3 event and market ecosystems.   Los Angeles, CA, 9th March 2026, ZEX PR WIRE — Rather than focusing solely on discovery, these

Los Angeles, CA, 9th March 2026, ZEX PR WIRE — Web3 markets are no longer short on data — they are overwhelmed by it. As digital asset ecosystems expand, both retail and institutional participants face a growing challenge: separating meaningful signals from fragmented information flows, duplicated narratives, and rapidly shifting sentiment.

Los Angeles, CA, 9th March 2026, ZEX PR WIRE — After months of focused development, DSCVR introduced the next evolution of its platform: an AI-native intelligence infrastructure designed to organize, interpret, and validate Web3’s fragmented data landscape.

Ad hoc announcement pursuant to Art. 53 LRBaar, Switzerland, 9 March 2026

Have you noticed? Lately, conversations among crypto veterans inevitably circle back to three “classical” pillars: compute power, energy, and mining hardware. When Ethereum completed its merge and many proclaimed the end of the PoW era, a quiet yet unshakable resurgence took root. Kaspa (KAS) — soaring hundreds of times in a single year — roared with the market’s hunger for “neo-classical” PoW: the reassuring solidity of time-tested consensus, paired with innovative solutions to longstanding pain points.

Bauwise announced the launch of Construction Tender Management, a new capability designed to address a common challenge in construction cost management: the gap between procurement and commercial control.

Canada - In a crowded field of online courses and rental “gurus,” BNB Authority has differentiated itself through a hands-on implementation model that prioritizes real-world execution over theory.

SPONSORED CONTENT -- (StatePoint) For travelers, diners, lunch counters and soda shops have stood the test of time as excellent places not only to get a meal, but to get a feel for the local culture.

SkyDrive Inc. (“SkyDrive”), a leading eVTOL (*1) aircraft manufacturer based in Japan, today announced that it has reached agreement with the Japan Civil Aviation Bureau (“JCAB”) on the General Certification Plan for its “SKYDRIVE” (SkyDrive Model SD-05). The agreement marks another major step forward in the aircraft’s type certification program (*2).

Discover the beauty of the Balkans with our custom & private tours, suited for your own travel style. Plan your next adventure today and explore new cultures!

The guide outlines measurable cleaning benchmarks, sterilization expectations, and workflow efficiency standards for modern parents

VANCOUVER, BC / ACCESS Newswire / March 9, 2026 / Lobe Sciences Ltd. (Lobe) (CSE:LOBE)(OTCQB:LOBEF)(Frankfurt:LOBE) is a Canadian public biopharmaceutical company incorporated in British Columbia, with principal executive offices in Florida. The Company identifies and advances therapeutic programs addressing significant unmet medical needs. Lobe is pleased to announce the promotion of Mr. Mirza Rahimani to Chief Financial Officer, effective March 2, 2026. Mr. Rahimani has been working with the Company since December 1, 2025, providing financial advisory services to management and the Board of Directors, and is now assuming the role of Chief Financial Officer.

The issuer is solely responsible for the content of this announcement.

SHENZHEN, CHINA - Media OutReach Newswire - 9 March 2026 - OPPO, the world's leading smart device brand, today announced the global launch of its latest...

Hong Kong, China--(Newsfile Corp. - March 8, 2026) - RecCloud announced an update to its AI speech-to-text platform, expanding complimentary...

GUANGZHOU, China, March 08, 2026 (GLOBE NEWSWIRE) -- WeRide (NASDAQ: WRD, HKEX: 0800), a global leader in autonomous driving technology, today signed an expanded strategic cooperation agreement with Geely’s Zhejiang Farizon New Energy Commercial Vehicle Group (Geely Farizon). The two companies announced plans to deliver 2,000 upgraded, purpose-built, mass-produced Robotaxi GXRs by 2026, advancing WeRide's progress toward large-scale global Robotaxi commercialization.

When he launched his boat onto Lake Waco for Saturday’s Knockout Round at Champion Teamwear Stage 3 Presented by MillerTech, pro Zack Birge of Blanchard, Oklahoma, knew next to nothing about the fishery. He’d never competed there before, and he spent all three days of official practice prior to the event on Lake Whitney, which hosted the two-day Qualifying Round.

The issuer is solely responsible for the content of this announcement.

The issuer is solely responsible for the content of this announcement.

Guitar legends Joe Satriani and Steve Vai are reuniting as the SatchVai Band for their first North American tour: Surfing With The Hydra 2026 ! Following a triumphant European run in 2025, this 40-date spring trek features a powerhouse lineup—Satriani and Vai on guitars, Kenny Aronoff (drums), Marco Mendoza (bass), and Pete Thorn (guitar)—plus special guest Animals As Leaders on every date for mind-bending instrumental prog-metal support.

KTO Los Angeles and its partners showcased Korea's diverse travel destinations and engaging cultural experiences to visitors at the 2026 Los Angeles Travel & Adventure Show.

Rock icon Melissa Etheridge is hitting the road in 2026 with The Rise Tour, supporting her powerful new album RISE and fresh single “Don’t You Want A Woman.” Fresh off her successful Yes We Are co-headline run with Indigo Girls, Etheridge brings her raw energy, soulful vocals, and signature guitar-driven anthems to intimate theaters and casinos across North America. Expect a high-octane setlist blending classics like “Come to My Window,” “I’m the Only One,” “Bring Me Some Water,” and “No Souvenirs” with new tracks from RISE —perfect for fans craving authentic, passionate live performances.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Barclays PLC (“Barclays” or “the Company”) (NYSE: BCS) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elauwit Connection, Inc. (“Elauwit” or “the Company”) (NASDAQ: ELWT) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of GrafTech International Ltd. (“GrafTech” or “the Company”) (NYSE: EAF) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of HF Sinclair Corporation (“HF Sinclair” or “the Company”) (NYSE: DINO) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Boston Scientific Corporation (“Boston Scientific” or “the Company”) (NYSE: BSX) for violations of the securities laws.

Did you buy ORCL common stock between June 12, 2025, and December 16, 2025?

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or the “Company”), a California-based global Embodied AI (EAI) ecosystem company, today shared a weekly business update from YT Jia, Founder and Global Co-CEO of FF.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Bright Horizons Family Solutions Inc. (“Bright Horizons” or “the Company”) (NYSE: BFAM) for violations of the securities laws.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sunrun Inc. (“Sunrun” or “the Company”) (NASDAQ: RUN) for violations of the securities laws.

NEW YORK, March 08, 2026 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) and Mereo BioPharma Group plc (NASDAQ:MREO). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of PROCEPT BioRobotics Corporation (“Procept” or “the Company”) (NASDAQ: PRCT) for violations of the securities laws.

NEW YORK, March 08, 2026 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of BlackRock TCP Capital Corp. (NASDAQ:TCPC) and Plug Power Inc. (NASDAQ: PLUG). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Agency Support Leader Shares 24/7 Premium Support Strategies for HighLevel Sustainability and Confident Scaling

Venu Holding Corporation ("VENU" or the “Company”) (NYSE American: VENU), a developer and operator of upscale live music venues and premium hospitality destinations, today announced the pricing of an underwritten public offering of 18,750,000 shares of common stock (or pre-funded warrants (“Pre-Funded Warrant”) in lieu thereof) and one accompanying warrant per share of common stock or Pre-Funded Warrant (“Warrant”). Each share of common stock or Pre-Funded Warrant is being sold to the public at a price of $4.00 (inclusive of the Pre-Funded Warrant exercise price), for gross proceeds of $75,000,000 before deducting underwriting fees and offering expenses. Each Warrant entitles the holder to purchase one share of common stock at an exercise price of $5.00 per share and will expire five years from the date of issuance. The shares of common stock (or Pre-Funded Warrants) and Warrants can only be purchased together in the offering, but will be issued separately. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 2,812,500 shares of common stock (or Pre-Funded Warrants) and/or additional 2,812,500 Warrants to cover over-allotments at the public offering price, less the underwriting discount. The offering is expected to close on March 10, 2026, subject to satisfaction of customary closing conditions.